Tekla Capital Management LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 8 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$1,879,000
+13.6%
1,485,0000.0%0.07%
+5.9%
Q2 2016$1,654,000
-25.0%
1,485,0000.0%0.07%
-27.7%
Q1 2016$2,205,000
+0.3%
1,485,0000.0%0.09%
+17.5%
Q4 2015$2,199,000
-5.9%
1,485,0000.0%0.08%
-4.8%
Q3 2015$2,336,000
-25.0%
1,485,0000.0%0.08%
-25.7%
Q2 2015$3,113,000
+6.3%
1,485,0000.0%0.11%
-2.6%
Q1 2015$2,929,000
+3.4%
1,485,0000.0%0.12%
-12.8%
Q4 2014$2,832,000
+22.7%
1,485,0000.0%0.13%
+23.1%
Q3 2014$2,308,000
+17.4%
1,485,0000.0%0.11%
-40.0%
Q2 2014$1,966,0001,485,0000.18%
Other shareholders

There were no reported owners of MERRIMACK PHARMACEUTICALS IN in Q4 2016.

NameSharesValueWeighting ↓
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders